Towards translational optogenetics
Optogenetics is widely used to interrogate the neural circuits underlying disease and has
most recently been harnessed for therapeutic applications. The optogenetic toolkit consists …
most recently been harnessed for therapeutic applications. The optogenetic toolkit consists …
GABAergic interneurons in epilepsy: More than a simple change in inhibition
JR Marafiga, MV Pasquetti, ME Calcagnotto - Epilepsy & Behavior, 2021 - Elsevier
The pathophysiology of epilepsy has been historically grounded on hyperexcitability
attributed to the oversimplified imbalance between excitation (E) and inhibition (I) in the …
attributed to the oversimplified imbalance between excitation (E) and inhibition (I) in the …
[HTML][HTML] Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy
C Lentini, M d'Orange, N Marichal, MM Trottmann… - Cell stem cell, 2021 - cell.com
Reprogramming brain-resident glial cells into clinically relevant induced neurons (iNs) is an
emerging strategy toward replacing lost neurons and restoring lost brain functions. A …
emerging strategy toward replacing lost neurons and restoring lost brain functions. A …
[HTML][HTML] Nav1. 1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer's disease
Inhibitory interneurons regulate the oscillatory rhythms and network synchrony that are
required for cognitive functions and disrupted in Alzheimer's disease (AD). Network …
required for cognitive functions and disrupted in Alzheimer's disease (AD). Network …
Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration
D Upadhya, B Hattiangady… - Proceedings of the …, 2019 - National Acad Sciences
Medial ganglionic eminence (MGE)-like interneuron precursors derived from human
induced pluripotent stem cells (hiPSCs) are ideal for developing patient-specific cell therapy …
induced pluripotent stem cells (hiPSCs) are ideal for developing patient-specific cell therapy …
[HTML][HTML] Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy
M Bershteyn, S Bröer, M Parekh, Y Maury, S Havlicek… - Cell Stem Cell, 2023 - cell.com
Mesial temporal lobe epilepsy (MTLE) is the most common focal epilepsy. One-third of
patients have drug-refractory seizures and are left with suboptimal therapeutic options such …
patients have drug-refractory seizures and are left with suboptimal therapeutic options such …
Beyond the hammer and the scalpel: selective circuit control for the epilepsies
E Krook-Magnuson, I Soltesz - Nature neuroscience, 2015 - nature.com
Current treatment options for epilepsy are inadequate, as too many patients suffer from
uncontrolled seizures and from negative side effects of treatment. In addition to these clinical …
uncontrolled seizures and from negative side effects of treatment. In addition to these clinical …
[HTML][HTML] Is mossy fiber sprouting a potential therapeutic target for epilepsy?
Mesial temporal lobe epilepsy (MTLE) caused by hippocampal sclerosis is one of the most
frequent focal epilepsies in adults. It is characterized by focal seizures that begin in the …
frequent focal epilepsies in adults. It is characterized by focal seizures that begin in the …
GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges
Diminution in the number of gamma-amino butyric acid positive (GABA-ergic) interneurons
and their axon terminals, and/or alterations in functional inhibition are conspicuous brain …
and their axon terminals, and/or alterations in functional inhibition are conspicuous brain …
[HTML][HTML] Mechanisms for cognitive impairment in epilepsy: moving beyond seizures
There has been a major emphasis on defining the role of seizures in the causation of
cognitive impairments like memory deficits in epilepsy. Here we focus on an alternative …
cognitive impairments like memory deficits in epilepsy. Here we focus on an alternative …